CORT vs. TXMD
Compare and contrast key facts about Corcept Therapeutics Incorporated (CORT) and TherapeuticsMD, Inc. (TXMD).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: CORT or TXMD.
Correlation
The correlation between CORT and TXMD is 0.25, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
CORT vs. TXMD - Performance Comparison
Key characteristics
CORT:
1.50
TXMD:
-0.28
CORT:
4.18
TXMD:
0.30
CORT:
1.57
TXMD:
1.04
CORT:
4.35
TXMD:
-0.29
CORT:
12.52
TXMD:
-0.74
CORT:
15.79%
TXMD:
38.83%
CORT:
122.13%
TXMD:
110.51%
CORT:
-94.28%
TXMD:
-99.99%
CORT:
-37.51%
TXMD:
-99.98%
Fundamentals
CORT:
$7.72B
TXMD:
$16.44M
CORT:
$1.23
TXMD:
-$0.20
CORT:
0.61
TXMD:
-0.73
CORT:
11.62
TXMD:
9.37
CORT:
11.36
TXMD:
0.60
CORT:
$685.45M
TXMD:
$2.12M
CORT:
$674.70M
TXMD:
$2.12M
CORT:
$111.33M
TXMD:
-$3.29M
Returns By Period
In the year-to-date period, CORT achieves a 41.66% return, which is significantly lower than TXMD's 62.79% return. Over the past 10 years, CORT has outperformed TXMD with an annualized return of 28.81%, while TXMD has yielded a comparatively lower -41.66% annualized return.
CORT
41.66%
1.26%
31.45%
181.02%
39.82%
28.81%
TXMD
62.79%
59.09%
-7.89%
-31.03%
-53.48%
-41.66%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
CORT vs. TXMD — Risk-Adjusted Performance Rank
CORT
TXMD
CORT vs. TXMD - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Corcept Therapeutics Incorporated (CORT) and TherapeuticsMD, Inc. (TXMD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
CORT vs. TXMD - Dividend Comparison
Neither CORT nor TXMD has paid dividends to shareholders.
Drawdowns
CORT vs. TXMD - Drawdown Comparison
The maximum CORT drawdown since its inception was -94.28%, smaller than the maximum TXMD drawdown of -99.99%. Use the drawdown chart below to compare losses from any high point for CORT and TXMD. For additional features, visit the drawdowns tool.
Volatility
CORT vs. TXMD - Volatility Comparison
The current volatility for Corcept Therapeutics Incorporated (CORT) is 16.59%, while TherapeuticsMD, Inc. (TXMD) has a volatility of 21.24%. This indicates that CORT experiences smaller price fluctuations and is considered to be less risky than TXMD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
CORT vs. TXMD - Financials Comparison
This section allows you to compare key financial metrics between Corcept Therapeutics Incorporated and TherapeuticsMD, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CORT vs. TXMD - Profitability Comparison
CORT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Corcept Therapeutics Incorporated reported a gross profit of 154.81M and revenue of 157.21M. Therefore, the gross margin over that period was 98.5%.
TXMD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, TherapeuticsMD, Inc. reported a gross profit of 667.00K and revenue of 667.00K. Therefore, the gross margin over that period was 100.0%.
CORT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Corcept Therapeutics Incorporated reported an operating income of 3.42M and revenue of 157.21M, resulting in an operating margin of 2.2%.
TXMD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, TherapeuticsMD, Inc. reported an operating income of -319.00K and revenue of 667.00K, resulting in an operating margin of -47.8%.
CORT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Corcept Therapeutics Incorporated reported a net income of 20.29M and revenue of 157.21M, resulting in a net margin of 12.9%.
TXMD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, TherapeuticsMD, Inc. reported a net income of 252.00K and revenue of 667.00K, resulting in a net margin of 37.8%.